Efficacy and safety of delta-9-tetrahydrocannabinol (delta-THC) in pain and pain related behavioural disturbances in dementia.
Phase of Trial: Phase II
Latest Information Update: 23 Jul 2015
At a glance
- Drugs Dronabinol (Primary) ; Paracetamol
- Indications Alzheimer's disease; Pain; Vascular dementia
- Focus Therapeutic Use
- 27 Jun 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 11 Dec 2013 Planned End Date changed from 1 Feb 2014 to 1 Mar 2014 as reported by ClinicalTrials.gov.
- 01 Aug 2013 Planned end date changed from 1 Dec 2013 to 1 Feb 2014 as reported by ClinicalTrials.gov.